Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Retrophin Inc. Shares Blasted Off
Motley Fool
Saturday, May 31, 2014 - 10:11am
tags:
Retrophin
Clovis Oncology Announces Encouraging Data from Phase 1/2a Study Evaluating Lucitanib in Advanced Solid Tumors
Yahoo/BusinessWire
Saturday, May 31, 2014 - 10:09am
tags:
Clovis Oncology, Lucitanib, breast cancer, non-small cell lung cancer
Amgen Highlights Phase 2 Results Of Vectibix Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer
Yahoo/PR NewsWire
Saturday, May 31, 2014 - 10:07am
tags:
Amgen, bevacizumab, colon cancer, colorectal cancer, Vectibix
Arena vs Vivus: Which Obesity Stock is a Buy? (video)
Motley Fool
Saturday, May 31, 2014 - 10:04am
tags:
Arena Pharmaceuticals, Vivus, obesity, weight loss, Belviq, Qsymia
Belviq Sales Climb - Are Ads Effective?
Seeking Alpha
Saturday, May 31, 2014 - 10:02am
tags:
Belviq, weight loss, obesity, Arena Pharmaceuticals, Eisai
Sequenom, Inc. Reports Sale Of Bioscience Business
Yahoo/PR NewsWire
Saturday, May 31, 2014 - 10:00am
tags:
Sequenom
Valeant ups the ante for Allergan instead of waiting for rejection
Marketwatch
Friday, May 30, 2014 - 4:42pm
tags:
Allergan, M&A, Valeant Pharmaceuticals
AbbVie heralds early success with its brain cancer-fighting armed antibody
Fierce Biotech
Friday, May 30, 2014 - 1:06pm
tags:
glioblastoma multiforme, ABT-414, AbbVie
Got a problem, doc? In Eli Lilly's brave new sales world, that's a plus
Fierce Pharma Marketing
Friday, May 30, 2014 - 1:04pm
tags:
Eli Lilly, sales models, physicians
Ex-ArthroCare CEO, CFO must face $400M fraud charges
Mass Device
Friday, May 30, 2014 - 1:03pm
tags:
devices, fraud, ArthroCare
Shire considering bid for NPS Pharmaceuticals - FT
Yahoo/Reuters
Friday, May 30, 2014 - 1:01pm
tags:
Shire, M&A, NPS Pharmaceuticals
A Vivus Buyout? Fat Chance And A Good Time To Short
Seeking Alpha
Friday, May 30, 2014 - 1:01pm
tags:
Vivus, M&A
Forest Labs wins U.S. antitrust approval to buy Furiex
Reuters
Friday, May 30, 2014 - 1:00pm
tags:
Forest Labs, Furiex Pharmaceuticals, M&A
GSK Keen to Keep Some Emerging Markets Drugs
TheStreet.com
Friday, May 30, 2014 - 12:30pm
tags:
GSK, emerging markets
Keryx Biopharma: Approval Delay Does Not Change Zerenex Prospects Or Differentiation
Seeking Alpha
Friday, May 30, 2014 - 12:28pm
tags:
Keryx, Zerenex
[video]Supreme Court + Risky Drug Launch = Billions at Stake
Motley Fool
Friday, May 30, 2014 - 12:25pm
tags:
Supreme Court, Teva Pharmaceuticals, Copaxone, generics, MS, multiple sclerosis
Pfizer: Why A Major Acquisition Or Break-Up Is Needed
Seeking Alpha
Friday, May 30, 2014 - 12:23pm
tags:
Pfizer, M&A
Johnson & Johnson Collaborates with Aduro BioTech
Yahoo/Zacks.com
Friday, May 30, 2014 - 12:22pm
tags:
JNJ, Aduro BioTech, prostate cancer
AstraZeneca’s resistance efforts rely on cancer drug advances
FT.com
Friday, May 30, 2014 - 10:37am
tags:
AstraZeneca, MEDI4736
[video]Could This be Pfizer's Best Incoming Drug?
Motley Fool
Friday, May 30, 2014 - 10:15am
tags:
Pfizer, palbociclib, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.